BIOS — BioPlus Acquisition Share News
0.000.00%
FinancialsAdventurousSmall Cap
- $271.14m
- $276.39m
Brief: Bioplus Acquisition Corp. Announces Termination Of Business Combination Agreement With Avertix Medical
Brief: Avertix To Become Publicly Traded Via Merger With Bios Acquisition Corp
Brief: BioPlus Acquisition Says Ceased Use Of Its Name In Marketing & Public Materials, Other Than When Use Of Co's Legal Name Is Needed In Certain Documents